Novartis AG vs STMicroelectronics NV — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while STMicroelectronics NV trades at $65.42 (market cap $55.80B). The key difference: Novartis AG is far larger — about 5.2× STMicroelectronics NV's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | STM | |
|---|---|---|
Market Cap | $290.25B | $55.80B |
Sector | Health | Financials |
52-Week High | $168.62 | $79.91 |
52-Week Low | $113.50 | $21.20 |
Enterprise Value | $330.27B | $54.01B |
Dividend Yield | 3.17% | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →